Other studies targeting TGFβ1 and αSMA in kidney diseases are in accordance with our results [58,59]; however, no studies have used exosomes for the treatment of fibrosis associated with CKD during the menopause period. The gene discussed is TGFB1; the disease is kidney disorder.